[C0 vs C2 levels and their implications in kidney transplantation]

Area of Science:

• Nephrology
• Pharmacokinetics
• Transplantation immunology

Background:

• Cyclosporine is a vital immunosuppressant in kidney transplantation.
• Monitoring drug levels is crucial for efficacy and safety.
• Different monitoring methods, including C0 and C2, have varying clinical utility.

Purpose of the Study:

• To compare the accuracy of C0 and C2 monitoring for assessing cyclosporine exposure in kidney transplant recipients.
• To evaluate the relationship between cyclosporine dosing, blood levels, and time post-transplant.

Main Methods:

• A trial involving 52 kidney transplant patients with stable function.
• Patients were categorized into three groups based on time post-transplantation (3-6 months, 6-12 months, >12 months).
• Blood samples were analyzed for C0 (trough) and C2 (2-hour post-dose) cyclosporine levels, alongside serum creatinine and Neoral dosage.

Main Results:

• Mean serum creatinine levels increased with time post-transplant (1.1, 1.3, 1.4 mg/dl).
• Mean Neoral doses decreased over time (5.5, 4.4, 3.0 mg/kg/day).
• Higher rates of Neoral overexposure were observed with C0 monitoring (40% in group 2, 41% in group 3), while C2 monitoring identified under-exposure in 24% of group 3 patients.

Conclusions:

• C0 monitoring is a poor predictor of graft exposure to cyclosporine.
• C2 monitoring provides a more accurate reflection of cyclosporine exposure in kidney transplant patients.
• Optimizing monitoring strategies can improve graft outcomes.